Sharda Cropchem Reports 20% Revenue Growth in Q2 FY26, Driven by Strong Volume Recovery

Sharda Cropchem Limited , a global agrochemical company, has reported a robust financial performance for the second quarter of fiscal year 2026, with significant growth in revenue and profitability. The company's strategic focus on product registrations and global market presence continues to drive its success.

Financial Highlights

Revenue: INR 929.00 crores in Q2 FY26, up 20% year-on-year
EBITDA: INR 139.00 crores, a 71% increase from the previous year
PAT: INR 74.00 crores, showing a 75% growth year-on-year
Gross Margin: Expanded by 690 basis points to 34.5%

Segment Performance

Segment	Revenue (INR Crores)	YoY Growth
Agrochemical	803.00	27%
Non-agrochemical	126.00	-11%

The agrochemical segment, which forms the core of Sharda Cropchem's business, demonstrated strong growth, while the non-agrochemical segment experienced a slight decline.

Volume Growth and Market Dynamics

Sharda Cropchem reported an impressive overall volume growth of 35% in Q2 FY26. The company's Chairman and Managing Director, Mr. R. V. Bubna, attributed this performance to a global revival in demand and recovery in prices. The agrochemical segment saw a 36% increase in volumes, while the non-agrochemical sector grew by 11%.

Product Registrations and Future Growth

As of September 30, 2025, Sharda Cropchem's total product registrations stood at 2,994, with an additional 1,068 applications pending approval. This extensive portfolio of registrations across various geographies positions the company well for future growth.

Region	Registered Products	Pending Applications
Europe	1,670	710
NAFTA	317	100
LATAM	759	160
Rest of World	248	98
Total	2,994	1,068

Financial Position and Outlook

Working Capital: Improved to 84 days from 118 days in March 2025
Cash Position: INR 794.00 crores in cash and liquid investments
Debt Status: The company remains debt-free

Management expects EBITDA margins to be in the range of 15-18% for the full year FY26. The company plans a capex of INR 450.00-500.00 crores, focusing on increasing product registrations to secure future growth.

H1 FY26 Performance

For the first half of FY26, Sharda Cropchem reported:

Revenue of INR 1,914.00 crores, a 23% year-on-year growth
PAT of INR 217.00 crores, representing a substantial 212% increase

Analyst Meeting Scheduled

Sharda Cropchem has announced an upcoming meeting with investors and analysts on November 13, 2025, organized by Anand Rathi in Mumbai. This meeting will provide an opportunity for stakeholders to gain further insights into the company's performance and strategies.

The company's strong performance in Q2 FY26, coupled with its expanding global presence and robust product registration pipeline, positions Sharda Cropchem favorably for continued growth in the agrochemical market.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+4.43%	+9.17%	+11.02%	+18.55%	+8.87%	+220.71%

Sharda Cropchem Limited , a prominent player in the generic crop protection chemicals industry, has set its sights on maintaining healthy EBITDA margins for the fiscal year 2026. The company's Managing Director has confirmed that Sharda Cropchem expects to achieve EBITDA margins in the range of 15-18% for FY26, signaling confidence in the company's operational efficiency and market position.

This target comes on the heels of a robust financial performance in the second quarter of the fiscal year 2026. According to the company's recently released financial results, Sharda Cropchem has demonstrated significant growth and improved profitability.

Q2 FY26 Financial Highlights

Particulars (in Rs. Crores)	Q2 FY26	Q2 FY25	Y-o-Y Growth
Revenue	929.10	776.90	20.00%
Gross Profit	320.70	214.70	49.00%
Gross Profit Margin	34.50%	27.60%	690 bps
EBITDA	138.90	81.30	71.00%
EBITDA Margin	15.00%	10.50%	450 bps
PAT	74.40	42.40	75.00%

The company has shown impressive year-on-year growth across key financial metrics. Revenue increased by 20% to Rs. 929.10 crores, while EBITDA saw a substantial 71% jump to Rs. 138.90 crores. The EBITDA margin for Q2 FY26 stood at 15.00%, a significant improvement of 450 basis points compared to the same quarter in the previous year.

Segment Performance

Sharda Cropchem's growth was primarily driven by its agrochemical segment, which contributed 86% of the total revenue. The segment reported a 27% year-on-year increase in revenue, reaching Rs. 803 crores in Q2 FY26.

Regional Performance

The company continued to see strong performance across its key markets:

Europe: Revenue grew by 15% to Rs. 463 crores
NAFTA: Showed remarkable growth of 69% to Rs. 214 crores
LATAM: Increased by 21% to Rs. 71 crores
Rest of the World: Also grew by 21% to Rs. 55 crores

Future Outlook

Ramprakash Bubna, Chairman and MD of Sharda Cropchem, commented on the results: "We expect prices to go up going forward. For FY26, we are on track to maintain healthy EBITDA margins in the range of 15–18%. We remain committed to accelerating product registrations in FY26, supported by a planned capital expenditure of Rs. 450–500 crores."

The company's strong registration pipeline of 1,068 products underscores its focus on sustained growth and market expansion. As of September 30, 2025, Sharda Cropchem had 2,994 product registrations, with 1,068 applications pending at various stages.

With a debt-free status and cash, bank, and liquid investments of Rs. 794 crores, Sharda Cropchem appears well-positioned to fund its growth initiatives and maintain its competitive edge in the global agrochemical market.

As the company aims to maintain its EBITDA margins between 15-18% for FY26, investors and industry observers will be keenly watching Sharda Cropchem's performance in the coming quarters to see if it can achieve this target amidst global market dynamics and potential challenges in the agrochemical sector.